Waning of maternal antibody against measles virus in Shufu, China

References

• Plotkin S, Orenstein W, Offit P. Vaccines. Philadelpha(PA): Elsevier; 2013.
   Google Scholar
• Measles rubella initiative Measles-Updated; 2020.
   Google Scholar
• World Health Organization. Measles vaccines: WHO position paper –april 2017. Weekly Epidemiol Rec. 2017;9217:1–5. doi:10.1016/j.vaccine.2017.07.066. PMID: 28760612.
   PubMedGoogle Scholar
• Thompson KM. Evolution and use of dynamic transmission models for measles and rubella risk and policy analysis. Risk Anal. 2016 PMID: 27277138;36(7):1383–403. doi:10.1111/risa.12637.
   PubMed Web of Science ®Google Scholar
• Orenstein WA, Cairns L, Hinman A, Nkowane B, Olivé J, Reingold AL. Measles and rubella global strategic plan 2012–2020 midterm review report: background and summary. Vaccine. 2018;36:A35–42. PMID: 29307368. doi:10.1016/j.vaccine.2017.10.065.
   PubMed Web of Science ®Google Scholar
• Patel MK, Goodson JL, Alexander JJ, Kretsinger K, Sodha SV, Steulet C, Gacic-Dobo M, Paul Rota PA, McFarland J, Menning L, et al. Progress toward regional measles elimination - worldwide, 2000-2019. MMWR Morb Mortal Wkly Rep. 2020;69(45):1700–05. PMID: 33180759. doi:10.15585/mmwr.mm6945a6.
   PubMed Web of Science ®Google Scholar
• Bozzola E, Spina G, Tozzi AE, Villani A. Global measles epidemic risk: current perspectives on the growing need for implementing digital communication strategies. Risk Manag Healthc Policy. 2020;13:2819–26. PMID: 33312006. doi:10.2147/RMHP.S201279.
   PubMed Web of Science ®Google Scholar
• Lo NC, Hotez PJ. Public health and economic consequences of vaccine hesitancy for measles in the United States. JAMA Pediatr. 2017 PMID: 28738137;171(9):887–92. doi:10.1001/jamapediatrics.2017.1695.
   PubMed Web of Science ®Google Scholar
• Zhang Z, Zhao Y, Yang L, Lu C, Meng Y, Guan X, An HJ, Zhang MZ, Guo WQ, Shang B, et al. Measles outbreak among previously immunized adult healthcare workers, China, 2015. Can J Infect Dis Med Microbiol. 2016;1742530. doi:10.1155/2016/1742530. PMID: 27366157.
   PubMed Web of Science ®Google Scholar
• Baccolini V, Sindoni A, Adamo G, Rosso A, Massimi A, Bella A, Filia A, Magurano F, Marzuillo C, Villari P, et al. Measles among healthcare workers in Italy: is it time to act? Hum Vaccin Immunother. 2020;16(11):2618–27. PMID: 32209017. doi:10.1080/21645515.2020.1737458.
   PubMed Web of Science ®Google Scholar
• Boulton ML, Wang X, Wagner AL, Zhang Y, Carlson BF, Gillespie BW, Ding YX. Measles antibodies in Mother–Infant Dyads in Tianjin, China. J Infect Dis. 2017 28968908;216(9):1122–29. doi:10.1093/infdis/jix453.PMID:.
   PubMed Web of Science ®Google Scholar
• Ma C, Hao L, Wen N, Fan CX, Yang H, Wang HQ, Ying ZD. Epidemiology of measles in China, 2019. Chin J Vaccines Immunization. 2020;5:493–97.
   Google Scholar
• Rejiafu S, Kuerban M, Xie N, Wusiman K, Sun L. Epidemiological characteristics of measles in Xinjiang, 2012–2018. Dis Surveill. 2019;12(34):1109–12. doi:10.3784/j.issn.1003-9961.2019.12.016.
   Google Scholar
• Zhang XY, Wang TM, Ma C, Liu HH, Zhang BK. Investigation of high measles incidence in Kashi prefecture of Xinjiang,2015. Dis Surveill. 2017;9(32):739–42. doi:10.3784/j.issn.1003-9961.2017.09.009.
   Google Scholar
• Lu L, Cao YM, Yang QY, He Q, Dong ZQ, Di B, Fu CX, Wang M. Dynamic maternal measles antibody level in infants: a longitudinal study. Zhonghua Liu Xing Bing Xue Za Zhi. 2016 PMID: 27188358;37(5):663–67. doi:10.3760/cma.j.issn.0254-6450.2016.05.015.
   PubMedGoogle Scholar
• Xu GZ, Ma R, Xu HJ, Ma YH, Dong HJ, Li Y, Hu FX, HoX N, Bian GL, Liang Y, et al. Levels of transition on maternal transferred measles antibody in infants in 3 cities in China. Zhonghua Liu Xing Bing Xue Za Zhi. 2008;29(11):1074–77. PMID: 19173926.
   PubMedGoogle Scholar
• Fu C, Lu L, Wu H, Shaman J, Cao Y, Fang F, Yang Q, He Q, Yang Z, Wang M, et al. Placental antibody transfer efficiency and maternal levels: specific for measles, coxsackievirus A16, enterovirus 71, poliomyelitis I-III and HIV-1 antibodies. Sci Rep. 2016;6(1):38874. doi:10.1038/srep38874. PMID:27934956.
   PubMedGoogle Scholar
• Science M, Savage R, Severini A, McLachlan E, Hughes SL, Arnold C, Richardson S, Crowcroft N, Deeks S, Halperin S, et al. Measles antibody levels in young infants. Pediatrics. 2019;144(6):e20190630. doi:10.1542/peds.2019-0630. PMID: 31753911.
   PubMed Web of Science ®Google Scholar
• Leuridan E, Hens N, Hutse V, Ieven M, Aerts M, Van Damme P. Early waning of maternal measles antibodies in era of measles elimination: longitudinal study. Bmj. 2010 20483946;340(may18 2):c1626. doi:10.1136/bmj.c1626. PMID: 20483946.
   PubMedGoogle Scholar
• Wang X, Xiu S, Jiang J, Lv L, Shi L, Sun F, et al. Study on epidemiological investigation of relative factors of maternal transferred measles antibody level in infants. Modern Prev Med. 2014;23(41):4282–83.
   Google Scholar
• Stigler SM. Regression towards the mean, historically considered. Stat Methods Med Res. 1997;6(2):103–14. PMID: 9261910. doi:10.1177/096228029700600202.
   PubMedGoogle Scholar
• Guerra FM, Crowcroft NS, Friedman L, Deeks SL, Halperin SA, Severini A, Hatchette TF, Bolotin S. Waning of measles maternal antibody in infants in measles elimination settings - A systematic literature review. Vaccine. 2018 29398276;36(10):1248–55. doi:10.1016/j.vaccine.2018.01.002.PMID:.
   PubMed Web of Science ®Google Scholar
• Chong KC, Rui Y, Liu Y, Zhou T, Jia K, Wang MH, Mohammad KN, He HQ. Early waning of maternal measles antibodies in infants in Zhejiang Province, China: a Comparison of Two Cross-Sectional Serosurveys. Int J Environ Res Public Health. 2019 31771262;16(23):4680. doi:10.3390/ijerph16234680.PMID:.
   PubMed Web of Science ®Google Scholar
• Ma C, Rodewald L, Hao L, Su Q, Zhang Y, Wen N, Fan CX, Yang H, Luo HM, Wang H, et al. Progress toward measles elimination — China, January 2013–june 2019. MMWR Morb Mortal Wkly Rep. 2019;68(48):1112–16. PMID: 31805034. doi:10.15585/mmwr.mm6848a2.
   PubMed Web of Science ®Google Scholar
• Yang Z, Xu J, Wang M, Di B, Tan H, He Q, Cai YS, Liang JH, Hu WS, Dong ZQ, et al. Measles epidemic from 1951 to 2012 and vaccine effectiveness in Guangzhou, southern China. Hum Vaccin Immunother. 2014;10(4):1091–96. PMID: 24513504. doi:10.4161/hv.27895.
   PubMed Web of Science ®Google Scholar
• Leuridan E, Van Damme P. Passive transmission and persistence of naturally acquired or vaccine-induced maternal antibodies against measles in newborns. Vaccine. 2007 PMID: 17629601;25(34):6296–304. doi:10.1016/j.vaccine.2007.06.020.
   PubMed Web of Science ®Google Scholar
• Zheng Y, Rodewald L, Yang J, Qin Y, Pang M, Feng L, Yu H. The landscape of vaccines in China: history, classification, supply, and price. BMC Infect Dis. 2018 PMID: 30286735;18(1):502. doi:10.1186/s12879-018-3422-0.
   PubMedGoogle Scholar
• Janusz CB, Wagner AL, Masters NB, Ding Y, Zhang Y, Hutton DW, Boulton ML. Measles vaccination of young infants in China: A cost-effectiveness analysis. Vaccine. 2020 PMID: 32451210;38(29):4616–24. doi:10.1016/j.vaccine.2020.04.079.
   PubMed Web of Science ®Google Scholar
• World Health Organization. Measles-Containing-Vaccine first-dose (MCV1) immunization coverage among 1-year-olds (%). 2021 Jul 13; [accessed 2022 Jan 1]. https://www.who.int/data/gho/data/indicators/indicator-details/GHO/measles-containing-vaccine-first-dose-mcv1-immunization-coverage-among-1-year-olds--.
   Google Scholar
• World Health Organization. Measles-Containing-Vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%). 2021 Jul 13; [accessed 2022 Jan 1]. https://www.who.int/data/gho/data/indicators/indicator-details/GHO/measles-containing-vaccine-second-dose-(mcv2)-immunization-coverage-by-the-nationally-recommended-age-(-).
   Google Scholar
• World Health Organization. Measles - number of reported cases. 2021 Jul 13, [accessed 2022 Jul 13]. https://www.who.int/data/gho/data/indicators/indicator-details/GHO/measles---number-of-reported-cases.
   Google Scholar
• Kuznetsova L, Cortassa G, Trilla A. Effectiveness of mandatory and incentive-based routine childhood immunization programs in Europe: a systematic review of the literature. Vaccines (Basel). 2021;9(10). PMID: 34696280. doi:10.3390/vaccines9101173.
   Web of Science ®Google Scholar
• Bechini A, Boccalini S, Ninci A, Zanobini P, Sartor G, Bonaccorsi G, Grazzini M, Bonanni P. Childhood vaccination coverage in Europe: impact of different public health policies. Expert Rev Vaccines. 2019 PMID: 31268739;18(7):693–701. doi:10.1080/14760584.2019.1639502.
   PubMed Web of Science ®Google Scholar
• Bozzola E, Spina G, Russo R, Bozzola M, Corsello G, Villani AMandatory vaccinations in European countries, undocumented information, false news and the impact on vaccination uptake: the position of the Italian pediatric societyItal J Pediatr20184416710.1186/s13052-018-0504-y PMID: 29898770
   PubMed Web of Science ®Google Scholar
• Cohen BJ, Doblas D, Andrews N. Comparison of plaque reduction neutralisation test (PRNT) and measles virus-specific IgG ELISA for assessing immunogenicity of measles vaccination. Vaccine. 2008;26(50):6392–97. doi:10.1016/j.vaccine.2008.08.074. PMID: 18834911.
   PubMed Web of Science ®Google Scholar